0.13%

Gold vs US Dollar

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
UK
LSE
Consol. Vend. (CVD)
Consol. Vend. (CVD) News

CVD Consol. Vend.

0.125

0.00 (0.00%)

01 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Consol. Vend.	LSE:CVD	London	Ordinary Share	GB00B1KZST66	ORD 0.1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	0.125						0.00	01:00:00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Covance to Present at UBS Global Life Sciences Conference

18/09/2009 5:24pm

PR Newswire (US)

Consol. Vend. (LSE:CVD)
Historical Stock Chart

From Jul 2019 to Jul 2024

Click Here for more Consol. Vend. Charts.

PRINCETON, N.J., Sept. 18 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the UBS Global Life Sciences Conference on Monday, September 21, 2009 at 10:00 a.m. (ET). Investors may access a live webcast of the presentation at http://www.covance.com/. In order to register and download any necessary software, please log on 10 minutes early. Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 10,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com/. DATASOURCE: Covance Inc. CONTACT: Investor Relations, +1-609-452-4807 Web Site: http://www.covance.com/